Category: Parkinson’s News

A new study links rare ITSN1 mutations to a tenfold increase in Parkinson’s risk, paving the way for targeted treatments.

Parkinson’s disease cases are projected to double globally by 2050, reaching 25 million individuals, according to a recent modeling study published in BMJ. Population aging (increasing median age) emerged as a primary driver of this increase, followed by population growth (rising total number of people), with the largest increases expected in East Asia and among people aged 80 and older.

A new study published in Cell Reports reveals a breakthrough discovery linking genetic variants in the gene ITSN1 to a significantly elevated risk of Parkinson’s disease, a neurodegenerative condition that affects nearly 2% of adults older than 65 years.

He was diagnosed with Parkinson’s at 33 years old after noticing changes in his handwriting.

Starting CPAP early may reduce that risk, VA data suggest

The 54-year-old is a professional quizzer and stand-up comedian

Abby FitzGerald, from Bromley in south London, noticed a subtle sign in her husband running technique which later turned out to be a sign of a life-changing condition.

Higher coffee consumption is causally linked to delayed onset of Parkinson’s disease but does not affect disease risk or progression, according to a Mendelian randomization study.

U.S. Deep Brain Stimulation In Parkinson’s Disease Market U.S. Deep Brain Stimulation In Parkinson’s Disease Market Dublin, Feb. 25, 2025 (GLOBE NEWSWIRE) — The “U.S. Deep Brain Stimulation In Parkinson’s Disease Market Size, Share & Trends Analysis Report By Product (Single-channel, Dual-channel), Competitive Analysis, And Segment Forecasts, 2025 – 2030” report has been added to ResearchAndMarkets.com’s offering.The U.S. deep brain stimulation in parkinson’s disease market size is anticipated